Explore the Global Next-Generation Sequencing (NGS) Workflow Quality Control Test Kits and Instruments Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Next-Generation Sequencing (NGS) Workflow Quality Control Test Kits and Instruments Market

Key Insight

FMI noted that the next-generation sequencing (NGS) workflow quality control test kits and instruments market was valued at USD 550 million in 2025. Demand is set to reach USD 596.2 million in 2026 and USD 1,335.6 million by 2036. QC instruments are projected to lead by product with 58.0% share in 2026 and Library QC is expected to lead by workflow stage through 2036.

April 16, 2026

Anurag Sharma

250 Pages

Cite this Report

Next-Generation Sequencing (NGS) Workflow Quality Control Test Kits and Instruments Market

https://www.futuremarketinsights.com/reports/next-generation-sequencing-ngs-workflow-quality-control-test-kits-and-instruments-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Agilent Technologies
Bio-Rad Laboratories
Illumina
Qiagen
Revvity
Roche Sequencing Solutions
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Next-Generation Sequencing (NGS) Workflow Quality Control Test Kits and Instruments Market

Key Players

Similar Industry Reports